Assaf Moore
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 6
-
- Prostate Cancer Diagnosis and Treatment 10
- Prostate Cancer Treatment and Research 7
- Renal cell carcinoma treatment 5
-
- Breast Cancer Treatment Studies 6
- Hepatology top 10%
- Radiation top 10%
- Advanced Radiotherapy Techniques 9
-
- Economic and Financial Impacts of Cancer 6
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 4
- Co-authors
- Michal SarfatyNoa GordonDaniel A. GoldsteinHadar GoldvaserTzippy ShochatEli RosenbaumVictoria NeimanMoshe Leshno
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
Assaf Moore
51 papers receiving 642 citations
Peers
Comparison fields: 5 of 69
- Oncology 339
- Pulmonary and Respiratory Medicine 277
- Cancer Research 122
- Hepatology 63
- Radiation 58
Countries citing papers authored by Assaf Moore
This map shows the geographic impact of Assaf Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Assaf Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Assaf Moore more than expected).
Fields of papers citing papers by Assaf Moore
This network shows the impact of papers produced by Assaf Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Assaf Moore. The network helps show where Assaf Moore may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Assaf Moore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 5 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 15 | |
| 5 | 2021 | 2 | |
| 6 | 2021 | 7 | |
| 7 | 2021 | 19 | |
| 8 | 2020 | 1 | |
| 9 | 2020 | 37 | |
| 10 | 2020 | 5 | |
| 11 | 2020 | 1 | |
| 12 | 2018 | 5 | |
| 13 | 2018 | 49 | |
| 14 | 2017 | 55 | |
| 15 | 2017 | 58 | |
| 16 | 2017 | 2 | |
| 17 | 2017 | 14 | |
| 18 | 2016 | 4 | |
| 19 | 1998 | 25 | |
| 20 | 1984 | 5 |
About Assaf Moore
Assaf Moore is a scholar working on Radiation, Oncology, Pulmonary and Respiratory Medicine, Otorhinolaryngology and Applied Microbiology and Biotechnology, having authored 52 papers that have together received 653 indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (10 papers), Advanced Radiotherapy Techniques (9 papers), Prostate Cancer Treatment and Research (7 papers), Economic and Financial Impacts of Cancer (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Breast Cancer Treatment Studies (6 papers), Renal cell carcinoma treatment (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). The work is most often cited by research in Oncology (339 citations), Pulmonary and Respiratory Medicine (277 citations), Cancer Research (122 citations), Hepatology (63 citations) and Radiation (58 citations). Assaf Moore has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Michal Sarfaty, Noa Gordon, Daniel A. Goldstein, Hadar Goldvaser, Tzippy Shochat, Eli Rosenbaum, Victoria Neiman, Moshe Leshno, Rinat Yerushalmi and Salomon M. Stemmer. Their work appears in journals such as Head & Neck, Cancer Medicine, Frontiers in Oncology, Journal of Clinical Oncology and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.